Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 196.93M
March 31, 2026 200.53M
December 31, 2025 180.07M
September 30, 2025 208.17M
June 30, 2025 164.59M
March 31, 2025 163.97M
December 31, 2024 288.27M
September 30, 2024 308.64M
June 30, 2024 401.59M
March 31, 2024 397.43M
December 31, 2023 453.93M
September 30, 2023 331.70M
June 30, 2023 132.84M
March 31, 2023 111.37M
December 31, 2022 112.55M
September 30, 2022 99.18M
June 30, 2022 114.36M
March 31, 2022 204.62M
December 31, 2021 144.45M
September 30, 2021 145.20M
June 30, 2021 232.13M
March 31, 2021 351.16M
December 31, 2020 383.93M
September 30, 2020 175.59M
June 30, 2020 105.29M
Date Value
March 31, 2020 81.40M
December 31, 2019 90.33M
September 30, 2019 104.00M
June 30, 2019 110.84M
March 31, 2019 116.62M
December 31, 2018 123.79M
September 30, 2018 146.88M
June 30, 2018 174.56M
March 31, 2018 159.23M
December 31, 2017 472.41M
September 30, 2017 454.10M
June 30, 2017 422.90M
March 31, 2017 400.34M
December 31, 2016 400.78M
September 30, 2016 391.47M
June 30, 2016 370.20M
March 31, 2016 350.57M
December 31, 2015 347.46M
September 30, 2015 349.55M
June 30, 2015 344.02M
March 31, 2015 321.38M
December 31, 2014 334.76M
September 30, 2014 292.74M
June 30, 2014 305.05M
March 31, 2014 286.20M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Becton, Dickinson & Co. 864.00M
DexCom, Inc. 1.818B
Abbott Laboratories --
Intuitive Surgical, Inc. 4.072B
Teleflex, Inc. 314.86M